ArticleVaccines2023

Pre-Clinical Safety and Immunogenicity Study of a Coronavirus Protein-Based Subunit Vaccine for COVID-19.

Kamshat Shorayeva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.